Iradimed (IRMD) Research & Development (2013 - 2026)
Iradimed (IRMD) reported Research & Development of $956000.0 for Q1 2026, up 53.21% year-over-year from $624000.0 in Q1 2025, and up 19.64% on a QoQ basis from $799031.0 in Q4 2025.
Iradimed (IRMD) has 14 years of Research & Development data on file, last reported at $956000.0 in Q1 2026.
- Quarterly Research & Development rose 53.21% year-over-year to $956000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 25.49% YoY) and the FY2025 annual result came in at $3.0 million, up 5.05% from the prior year.
- Research & Development climbed to $956000.0 in Q1 2026 per IRMD's latest filing, from $799031.0 in the prior quarter.
- Across five years, Research & Development topped out at $3.0 million in Q1 2023 and bottomed at $452555.0 in Q3 2023.
- The 5-year median for Research & Development is $662599.0 (2022), against an average of $829750.2.
- The widest annual swing landed in 2023, when Research & Development surged 477.92%; it then tumbled 72.63% in 2024.
- Tracing IRMD's Research & Development over 5 years: stood at $604744.0 in 2022, then gained by 7.56% to $650435.0 in 2023, then fell by 12.3% to $570404.0 in 2024, then jumped by 40.08% to $799031.0 in 2025, then advanced by 19.64% to $956000.0 in 2026.
- Per Business Quant, the three latest IRMD Research & Development figures stand at $956000.0 (Q1 2026), $799031.0 (Q4 2025), and $674362.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 956,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 956,000.00 |
| Dec 31, 2025 | 799,031.00 |
| Sep 30, 2025 | 674,362.00 |
| Jun 30, 2025 | 877,362.00 |
| Mar 31, 2025 | 624,000.00 |
| Dec 31, 2024 | 570,404.00 |
| Sep 30, 2024 | 639,467.00 |
| Jun 30, 2024 | 801,129.00 |
| Mar 31, 2024 | 821,000.00 |
| Dec 31, 2023 | 650,435.00 |
| Sep 30, 2023 | 452,555.00 |
| Jun 30, 2023 | 961,952.00 |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 604,744.00 |
| Sep 30, 2022 | 491,643.00 |
| Jun 30, 2022 | 662,599.00 |
| Mar 31, 2022 | 519,095.00 |
| Dec 31, 2021 | 494,851.00 |
| Sep 30, 2021 | 480,696.00 |
| Jun 30, 2021 | 453,679.00 |
| Mar 31, 2021 | 475,817.00 |
| Dec 31, 2020 | 512,718.00 |
| Sep 30, 2020 | 476,876.00 |
| Jun 30, 2020 | 482,654.00 |
| Mar 31, 2020 | 430,282.00 |
| Dec 31, 2019 | 379,310.00 |
| Sep 30, 2019 | 369,526.00 |
| Jun 30, 2019 | 331,310.00 |
| Mar 31, 2019 | 352,573.00 |
| Dec 31, 2018 | 367,715.00 |
| Sep 30, 2018 | 373,583.00 |
| Jun 30, 2018 | 395,988.00 |
| Mar 31, 2018 | 379,826.00 |
| Dec 31, 2017 | 349,559.00 |
| Sep 30, 2017 | 382,704.00 |
| Jun 30, 2017 | 449,011.00 |
| Mar 31, 2017 | 541,290.00 |
| Dec 31, 2016 | 364,216.00 |
| Sep 30, 2016 | 457,134.00 |
| Jun 30, 2016 | 291,822.00 |
| Mar 31, 2016 | 234,336.00 |
| Dec 31, 2015 | 499,996.00 |
| Sep 30, 2015 | 518,562.00 |
| Jun 30, 2015 | 403,447.00 |
| Mar 31, 2015 | 342,301.00 |
| Dec 31, 2014 | 315,407.00 |
| Sep 30, 2014 | 303,463.00 |
| Jun 30, 2014 | 225,500.00 |
| Mar 31, 2014 | 224,304.00 |
| Dec 31, 2013 | 345,615.00 |
| Sep 30, 2013 | 299,422.00 |
| Jun 30, 2013 | 204,423.00 |